Adjusted mean difference versus placebo in change from baseline in HbA@c at week @ was -@ % ( @ % CI -@ , -@ ) ( -@ mmol/mol -LSB- @ % CI -@ , -@ -RSB- ) with @ mg empagliflozin and -@ % ( @ % CI -@ , -@ ) ( -@ mmol/mol -LSB- @ % CI -@ , -@ -RSB- ) with @ mg empagliflozin ( both P < @ ) .